These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9173018)

  • 41. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

  • 42. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users.
    Lyvers M
    Addiction; 2011 Apr; 106(4):787-8. PubMed ID: 21371152
    [No Abstract]   [Full Text] [Related]  

  • 44. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 47. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
    Bailly D
    Encephale; 1999; 25(6):595-602. PubMed ID: 10668603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Prada C; Alvarez FJ
    Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
    [No Abstract]   [Full Text] [Related]  

  • 52. [Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
    Nielsen JC; Nicholson K; Pitzner-Jørgensen BL; Undén M
    Ugeskr Laeger; 1995 Feb; 157(6):724-7. PubMed ID: 7701630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [MDMA--"ecstasy"].
    Keup W
    Med Monatsschr Pharm; 1996 Jan; 19(1):2-5. PubMed ID: 8583979
    [No Abstract]   [Full Text] [Related]  

  • 54. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users.
    Tuchtenhagen F; Daumann J; Norra C; Gobbelé R; Becker S; Pelz S; Sass H; Buchner H; Gouzoulis-Mayfrank E
    Neuropsychopharmacology; 2000 Jun; 22(6):608-17. PubMed ID: 10788760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Parrott AC; Sisk E; Turner JJ
    Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The agony of ecstasy: responding to growing MDMA use among college students.
    Walters ST; Foy BD; Castro RJ
    J Am Coll Health; 2002 Nov; 51(3):139-41. PubMed ID: 12638995
    [No Abstract]   [Full Text] [Related]  

  • 58. The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine.
    Traub SJ; Hoffman RS; Nelson LS
    J Urban Health; 2002 Dec; 79(4):549-55. PubMed ID: 12468674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurotoxicity of MDMA: Main effects and mechanisms.
    Costa G; Gołembiowska K
    Exp Neurol; 2022 Jan; 347():113894. PubMed ID: 34655576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    Kish SJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):845-55. PubMed ID: 11888575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.